The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Coloman I.I.

Russian Medical Academy of Continuous Professional Education

Levin O.S.

Russian Medical Academy of Continuous Professional Education

Thermoregulatory dysfunction in Parkinson's disease

Authors:

Coloman I.I., Levin O.S.

More about the authors

Read: 13533 times


To cite this article:

Coloman II, Levin OS. Thermoregulatory dysfunction in Parkinson's disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(10‑2):69‑75. (In Russ.)
https://doi.org/10.17116/jnevro202112110269

Recommended articles:
Sleep diso­rders in patients with Lewy body deme­ntia and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):81-87
Art and creativity in Parkinson’s disease: the mysterious effe­cts of dopa­mine. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):13-20
Correlation of motor symptoms and cardiovascular dysfunction in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):59-67
Effect of uric acid on the progression of Parkinson’s disease: Myth or reality?. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):7-14
Oxidative stress and depression in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):131-138

References:

  1. LeDoux MS. Thermoregulatory Dysfunction in Parkinson’s Disease In: Pfeiffer R.F., Bodis-Wollner I. (eds.), Parkinson’s Disease and Nonmotor Dysfunction, Current Clinical Neurology, Humana Press. 2013. https://doi.org/10.1007/978-1-60761-429-6_14
  2. Kelso SR, Perlmutter MN, Boulant JA. Thermosensitive single-unit activity of in vitro hypothalamic slices. Am J Physiol. 1982;242(1):77-84.  https://doi.org/10.1152/ajpregu.1982.242.1.R77
  3. Smith J, Jansen A, Gilbey M, Loewy A. CNS cell groups projecting to sympathetic outflow of tail artery: neural circuits involved in heat loss in the rat. Brain Research. 1998;786(1-2):153-164. 
  4. Lin MT, Chandra A, Tsay BL, Chern YF. Hypothalamic and striatal dopamine receptor activation inhibits heat production in the rat. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 1982;242(5):45-49.  https://doi.org/10.1152/ajpregu.1982.242.5.R471
  5. Scott I, Boulant J. Dopamine effects on thermosensitive neurons in hypothalamic tissue slices. Brain Research. 1984;306(1-2):157-163.  https://doi.org/10.1016/0006-8993(84)90364-0
  6. Hasegawa H, Yazawa T, Yasumatsu M. et al. Alteration in dopamine metabolism in the thermoregulatory center of exercising rats. Neurosci Lett. 2000;289(3):161-164.  https://doi.org/10.1016/s0304-3940(00)01276-3
  7. Salmi P. Independent roles of dopamine D1 and D2/3 receptors in rat thermoregulation. Brain Res. 1998;781(1-2):188-193.  https://doi.org/10.1016/s0006-8993(97)01229-8
  8. Perachon S, Betancur C, Pilon C. et al. Role of dopamine D3 receptors in thermoregulation: a reappraisal. Neuroreport. 2000;11(1):221-225.  https://doi.org/10.1097/00001756-200001170-00044
  9. Lefrant JY, Muller L, de La Coussaye JE, et al. Temperature measurement in intensive care patients: comparison of urinary bladder, oesophageal, rectal, axillary, and inguinal methods versus pulmonary artery core method. Intensive Care Med. 2003;29(3):414-418.  https://doi.org/10.1007/s00134-002-1619-5
  10. Fulbrook P. Core body temperature measurement: a comparison of axilla, tympanic membrane and pulmonary artery blood temperature. Intensive Crit Care Nurs. 1997;13(5):266-272. PMID: 9538713. https://doi.org/10.1016/S0964-3397(97)80425-9
  11. Odinak MM, Kotelnikova SA, Shustov EB. Vyzvannye kozhnye vegetativnye potencialy: metodicheskie ukazanija. Ivanovo: Nejrosoft; 1999. (In Russ.).
  12. Knezevic W, Bajada S. Peripheral autonomic surface potential. A quantitative technique for recording sympathetic conduction in man. J Neurol Sci. 1985;67(2):239-251.  https://doi.org/10.1016/0022-510X(85)90120-0
  13. Low PA, Opfer-Gehrking TL, Kihara M. In vivo studies on receptor pharmacology of the human eccrine sweat gland. Clin Auton Res. 1992;2(1):29-34.  https://doi.org/10.1007/bf01824208
  14. Cohen J, Low P, Fealey R, et al. NS. Somatic and autonomic function in progressive autonomic failure and multiple system atrophy. Ann Neurol. 1987;22(6):692-699.  https://doi.org/10.1002/ana.410220604
  15. Fealey RD, Low PA, Thomas JE. Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc. 1989;64(6):617-628.  https://doi.org/10.1016/S0025-6196(12)65338-5
  16. Gubbay SS, Barwick DD. Two cases of accidental hypothermia in Parkinson’s disease with unusual E.E.G. findings. J Neurol Neurosurg Psychiatry. 1966;29(5):459-466.  https://doi.org/10.1136/jnnp.29.5.459
  17. Siddiqui MF, Rast S, Lynn M, et al. Autonomic dysfunction in Parkinson’s disease: a comprehensive symptom survey. Parkinsonism Relat Disord. 2002;8(4):277-284.  https://doi.org/10.1016/S1353-8020(01)00052-9
  18. Gowers WR. A manual of disease of nervous system. Philadelphia: Blakiston; 1888.
  19. Charcot JM. Maladies de système nerveux, vol. 1. Paris: Battaille; 1892.
  20. Lees AJ. When did Ray Kennedy’s Parkinson’s disease begin? Mov Disord. 1992;7(2):110-116.  https://doi.org/10.1002/mds.870070203
  21. Pursiainen V, Haapaniemi TH, Korpelainen J. et al. Sweating in Parkinsonian patients with wearing-off. Mov Disord. 2007;22(6):828-832.  https://doi.org/10.1002/mds.21422
  22. Appenzeller O, Goss JE. Autonomic deficits in Parkinson’s syndrome. Arch Neurol. 1971;24(1):50-57.  https://doi.org/10.1001/archneur.1971.00480310078007
  23. Sage JI, Mark MH. Drenching sweats as an off phenomenon in Parkinson’s disease: treatment and relation to plasma levodopa profile. Ann Neurol. 1995;37(1):120-122.  https://doi.org/10.1002/ana.410370124
  24. Pfeiffer RF, Sucha EL. «On-off»-induced lethal hyperthermia. Mov Disord. 1989;4(4):338-341.  https://doi.org/10.1002/mds.870040408
  25. Keyser DL, Rodnitzky RL. Neuroleptic malignant syndrome in Parkinson’s disease after withdrawal or alteration of dopaminergic therapy. Arch Intern Med. 1991;151(4):794-796. PMID: 1672810.
  26. Gordon PH, Frucht SJ. Neuroleptic malignant syndrome in advanced Parkinson’s disease. Mov Disord. 2001;16(5):960-962.  https://doi.org/10.1002/mds.1166
  27. Mizuta E, Yamasaki S, Nakatake M, Kuno S. Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period. Neurology. 1993;43(5):1048-1049. https://doi.org/10.1212/wnl.43.5.1048
  28. Serrano-Dueñas M. Neuroleptic malignant syndrome-like, or — dopaminergic malignant syndrome — due to levodopa therapy withdrawal. Clinical features in 11 patients. Parkinsonism Relat Disord. 2003;9(3):175-178.  https://doi.org/10.1016/S1353-8020(02)00035-4
  29. Goetz CG, Lutge W, Tanner CM. Autonomic dysfunction in Parkinson’s disease. Neurology. 1986;36(1):73-75.  https://doi.org/10.1212/WNL.36.1.73
  30. Sandroni P, Ahlskog JE, Fealey RD, Low PA. Autonomic involvement in extrapyramidal and cerebellar disorders. Clin Auton Res. 1991;1(2):147-155.  https://doi.org/10.1007/bf01826212
  31. Haapaniemi TH, Korpelainen JT, Tolonen U. et al. Suppressed sympathetic skin response in Parkinson disease. Clin Auton Res. 2000;10(6):337-342.  https://doi.org/10.1007/bf02322257
  32. Turkka JT, Myllylä VV. Sweating dysfunction in Parkinson’s disease. Eur Neurol. 1987;26(1):1-7.  https://doi.org/10.1159/000116304
  33. Kihara M, Kihara Y, Tukamoto T, et al. Assessment of sudomotor dysfunction in early Parkinson’s disease. Eur Neurol. 1993;33(5):363-365.  https://doi.org/10.1159/000116972
  34. Hirashima F, Yokota T, Hayashi M. Sympathetic skin response in Parkinson’s disease. Acta Neurol Scand. 1996;93(2-3):127-132.  https://doi.org/10.1111/j.1600-0404.1996.tb00187.x
  35. De Marinis M, Stocchi F, Testa S, et al. Alterations of thermoregulation in Parkinson’s disease. Funct Neurol. 1991;6(3):279-283. 
  36. Korpelainen JT, Sotaniemi KA, Myllylä VV. Autonomic nervous system disorders in stroke. Clin Auton Res. 1999;9(6):325-333.  https://doi.org/10.1007/bf02318379
  37. Ueno M, Tokunaga Y, Terachi S, et al. Asymmetric sweating in a child with multiple sclerosis. Pediatr Neurol. 2000;23(1):74-76.  https://doi.org/10.1016/s0887-8994(00)00155-7
  38. Smith CD. A hypothalamic stroke producing recurrent hemihyperhidrosis. Neurology. 2001;56(10):1394-1396. https://doi.org/10.1212/wnl.56.10.1394
  39. Kimpinski K, Iodice V, Burton DD, et al. The role of autonomic testing in the differentiation of Parkinson’s disease from multiple system atrophy. J Neurol Sci. 2012;317(1-2):92-96.  https://doi.org/10.1016/j.jns.2012.02.023
  40. Raupach AK, Ehgoetz KA, Memarian N, et al. Assessing the role of nocturnal core body temperature dysregulation as a biomarker of neurodegeneration. J Sleep Res. 2020;29(5):e12939. https://doi.org/10.1111/jsr.12939
  41. Langston JW, Forno LS. The hypothalamus in Parkinson disease. Ann Neurol. 1978;3(2):129-133.  https://doi.org/10.1002/ana.410030207
  42. Dabby R, Djaldetti R, Shahmurov M, et al. Skin biopsy for assessment of autonomic denervation in Parkinson’s disease. J Neural Transm (Vienna). 2006;113(9):1169-1176. https://doi.org/10.1007/s00702-005-0431-0
  43. Mostile G, Jankovic J. Treatment of dysautonomia associated with Parkinson’s disease. Parkinsonism Relat Disord. 2009;15(suppl 3):224-232.  https://doi.org/10.1016/S1353-8020(09)70820-X
  44. Naumann M, Dressler D, Hallett M, et al. Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders. Toxicon. 2013;67:141-152.  https://doi.org/10.1016/j.toxicon.2012.10.020
  45. Jankovic J. Disease-oriented approach to botulinum toxin use. Toxicon. 2009;54(5):614-623.  https://doi.org/10.1016/j.toxicon.2008.11.013
  46. Martignoni E, Godi L, Pacchetti C, et al. Is seborrhea a sign of autonomic impairment in Parkinson’s disease? J Neural Transm (Vienna). 1997;104(11-12):1295-1304. https://doi.org/10.1007/bf01294730
  47. Fischer M, Gemende I, Marsch WC, Fischer PA. Skin function and skin disorders in Parkinson’s disease. J Neural Transm (Vienna). 2001;108(2):205-213.  https://doi.org/10.1007/s007020170088
  48. Clapham JC. Central control of thermogenesis. Neuropharmacology. 2012;63(1):111-123.  https://doi.org/10.1016/j.neuropharm.2011.10.014
  49. Meeusen R, Roelands B. Central fatigue and neurotransmitters, can thermoregulation be manipulated? Scand J Med Sci Sports. 2010;20(suppl 3):19-28.  https://doi.org/10.1111/j.1600-0838.2010.01205.x
  50. Bjerknes S, Skogseid I, Hauge T. et al. Subthalamic deep brain stimulation improves sleep and excessive sweating in Parkinson’s disease. npj Parkinsons Dis. 2009;6:34-39.  https://doi.org/10.1038/s41531-020-00131-0

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.